Health Condition 1: K519- Ulcerative colitis, unspecified
Conditions
Interventions
None listed
Sponsors
Microbes formulas
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: 18 Yrs to 60 Yrs 2. Gender: Male, female, transgender 3.Must sign the informed consent form 4. Documented diagnosis (based on Ayurvedic criteria, Sigmoidoscopy and biopsy) of ulcerative colitis 5. If treated with oral corticosteroids, dose must not increase 20 mg per day of Prednisolone or equivalent.
Exclusion criteria
Exclusion criteria: 1. Severe ulcerative colitis indicated by Disease Activity Index score of greater than 10 2. Presence of any other medical condition. 3. Participants receiving therapy with cyclosporin, anti-TNF therapy, or methotrexate within the last 2 months of screening. 4. History of chronic liver disease or baseline liver chemistries greater than the upper limit of normal 5. Diabetes mellitus requiring hypoglycemic agents 6. Has any of the following laboratory abnormalities: WBC 7. Participant is female and is pregnant or currently breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Frequency of stool (Urgency) 2.Blood in stool (Bloody diarrhea) 3.Pain abdomen and discomfort (Tenesmus) 4.Body strength 5.Weight loss 6.Appetite 7.Mental status 8.Sigmoidoscopy (Before and after the study) 9.Biopsy (Before and after the study)Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in hospital visits after completing the trialTimepoint: 10 weeks | — |
Countries
India
Contacts
Public ContactDr Chander Shekhar Sharma
Dayanand Ayurvedic College, jalandhar
Outcome results
None listed